Shares of Vitae Pharmaceuticals Inc. (NASDAQ: VTAE) were downgraded by analysts at Wedbush in a note to itheir nvestors today.Meanwhile, a number of other analysts have commented on the stock recently, and the company currently has a consensus one-year price target of $21.00, higher than the opening price of $20.81, a difference of percent. Vitae Pharmaceuticals Inc. has 52-week high of $20.97.
Stock prices often move to the upside on recommendations and new price targets of professional analysts.
Downgrades occur when analysts feel that the future prospects for the security have weakened from the original recommendation, usually due to a material and fundamental change in the company’s operations, future outlook or industry.
U.S. stocks finished sharply lower on Tuesday as equities slid amid a slump in energy shares and continued uncertainty about the Federal Reserve’s plans for monetary policy.
The Dow Jones Industrial Average DJIA, -1.41% closed 258.05 points, or 1.4%, lower at 18,066.89, and was down nearly 300 points at its lowest.
The S&P 500 index SPX, -1.48% gave up 32.02 points, or 1.5%, at 2,127.02.
Meanwhile, the Nasdaq Composite Index COMP, -1.09% fell 56.63 points, or 1.1%, at 5,155.25.
In early action today stocks are moving up with the Dow being led by Apple.
Apple Inc. AAPL, is up +2.69% and climbed 0.9%.
Shares of Vitae Pharmaceuticals Inc. (NASDAQ: VTAE) opened at $20.81 and traded in a range between, $20.81 and $20.97 yesterday, and last traded at $20.85, which represents a change of $ 12.75 over the previous closing price.
Vitae Pharmaceuticals Inc. (NASDAQ: VTAE) now has a market cap of 601.33M
By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.
A moving average can also act as support or resistance. In an uptrend a 50-day, or a 200-day moving average may act as a support level.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
With that in mind Vitae Pharmaceuticals Inc. (NASDAQ: VTAE) now has a 50-day MA is $8.81 and 200-day MA is $8.49, and it has traded in a 52-week range between $4.08 – 20.97 and yesterday’s last price was -0.57 percent off the 52 week high of $20.97.
The stocks average daily volume is 782,039 shares out of a total float 18,668,000 of and some 33,714,406 shares crossed the trading desk yesterday, 14 percent higher than normal. Significant increases in trading volume and price appreciation together could signal heavy volume accumulation by institutional investors.
While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.
Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Professional investors such as these retain substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
Indeed, earnings growth is among the most important things to look in regards to stock investing and, accordingly, investors seek companies who have been successful at growing their earnings by at least 25 percent over a 3 year period.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of The Woodbridge Citizen. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please see our terms and conditions page.